New drug cocktail aims to shrink colorectal tumors
NCT ID NCT06722183
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial tests a combination of two drugs—futibatinib (a daily pill) and tislelizumab (an IV immunotherapy)—in adults with advanced colorectal cancer. The goal is to see if the combo can shrink tumors and to identify biomarkers that predict response. About 33 people will take part.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Futibatinib (a targeted cancer pill) combined with tislelizumab (an immunotherapy drug given by IV)
- What this could lead to
- If successful, this could point toward a new treatment option for colorectal cancer that combines targeted therapy with immunotherapy to shrink tumors.
- What could go wrong
- This is an early phase 2 trial with only 33 participants, so results may not apply to all patients. The combination may cause side effects or fail to improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Charité Campus Virchow Klinikum (CVK)
NOT_YET_RECRUITINGBerlin, Germany
-
Hope Hamburg
RECRUITINGHamburg, Germany
-
Kliniken Essen-Mitte
RECRUITINGEssen, Germany
-
Klinikum München rechts der Isar
RECRUITINGMünchen, Germany
-
Klinikum St. Marien Amberg
NOT_YET_RECRUITINGAmberg, Germany
-
Krankenhaus Nordwest
RECRUITINGFrankfurt am Main, 60488, Germany
-
Leopoldina Krankenhaus Schweinfurt
RECRUITINGSchweinfurt, Germany
-
MVZ für Hämatologie und Onkologie Ravensburg GmbH
NOT_YET_RECRUITINGRavensburg, 88212, Germany
-
Universitätsklinikum Düsseldorf
RECRUITINGDüsseldorf, Germany
-
Universitätsmedizin Mainz
NOT_YET_RECRUITINGMainz, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?